Formalized FDA Clinical Trial
Saturday, February 21st, 2009As Many of us know Keratoconus affects the lives of several thousand patients each year. Keratoconus affects the lives of the patients suffering and the family of each patient. Insurance companies recognize cornea transplant as a treatment for Keratoconus. Many surgeons have realized that treatments such as INTACS and C3R provide little to no risk for complications and fast recovery. While insurance companies have started to pay for INTACS, they continue to deny C3R, which holds little if any complication.
While many attempts have been made in the past to create better treatment many are now looking at the possibility of a cure for Progressive Keratoconus and Corneal Ectasia. According to the National Keratoconus Foundation [NKCF] two FDA studies were started in January of 2008 to study the effectiveness of Corneal Collagen Crosslinking on patients with Progressive Keratoconus and Corneal Ectasia. These studies were to begin with 160 patients with Progressive Keratoconus and 160 patients with Corneal Ectaisia. The patients would be studied for 3-6 months and than be followed for an additional 12 months there after. A formal study is the first step to gaining insurance approval for payment.
Quote:
“We are extremely excited to begin clinical trials on Cross Linking. It maybe a way to cure a disease that has no current treatment and accounts for 15% of transplants preformed in the United States. “
Says: Principal Investor-
While the study is winding down, and we should see the difference in the report. Many can already tell you of the benefits of Corneal Collagen Cross with Riboflavin. The results have been positive the little to no side effects or complications. Most who have use the treatment reported noticeable changes in at least 48 hours and the most substantial change within the last 2 weeks.
Progressive Keratoconus thins the corneal walls causing irregular changes in the shape of the cornea and distorts your vision. The C3R treatment stregthens the fibers of the Cornea walls restoring the natural shape. The treatment is non-invasive unlike the Cornea Transplant that were the primary treatment for Progressive Keratoconus. The treatment can be preformed in the doctors’ office within 30 minutes-the procedure is comfortable and even better no reduction in activity is necessary.
Progressive Keratoconus patients now have new hope. Many doctors are looking at this for a possible “cure” for these debilitating diseases. Early detection is the key to reduced complications. Below are a few symptoms of Progressive Keratoconus. If you have any of these symptoms consult your physician early.
Progressive Keratoconus Symptoms:
High Astigmatism
Increased Astigmatism
Headaches [Due to eye strain]
Disturbed night vision
Sensitivity to Light
Blurred Vision
To Watch a free educational video on treatments for Keratoconus visit: www.FixesYourKC.com
Now you can follow us on Facebook and Twitter:




